Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Head & Neck 1Dermatologic 1

Conditions

Ovarian Neoplasms 2Breast Neoplasms 2Melanoma 1Head and Neck Neoplasms 1

Interventions

Trastuzumab 628Paclitaxel 577Cyclophosphamide 555Docetaxel 485Capecitabine 402Letrozole 376Fulvestrant 327Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 186Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 139Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × technetium Tc 99m nanocolloid × Clear all
NCT04487912 2021-05-14

Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer

University Hospital, Ghent

Phase 4 Withdrawn
Breast

Breast Neoplasms

NCT04261179 2020-02-20

SENTINELSEEK

Fundacion Clinic per a la Recerca Biomédica

Phase 4 Unknown
30 enrolled
BreastDermatologicHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡